Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
He M, Soni B, Schwalie PC, Hüsser T, Waltzinger C, De Silva D, Prinz Y, Krümpelmann L, Calabro S, Matos I, Trumpfheller C, Bacac M, Umaña P, Levesque MP, Dummer R, van den Broek M, Gasser S.
He M, et al. Among authors: soni b.
J Immunother Cancer. 2022 Jun;10(6):e004268. doi: 10.1136/jitc-2021-004268.
J Immunother Cancer. 2022.
PMID: 35688559
Free PMC article.